Effect of lipopolysaccharides from Porphyromonas endodontalis on the expression of interleukin-34 in mouse osteoblasts

doi:10.19439/j.sjos.2017.01.008

Abstract

Abstract: PURPOSE: To investigate the effects of lipopolysaccharides (LPS) extracted from Porphyromonas endodontalis (P.e) on the expression of interleukin-34 (IL-34) mRNA in MC3T3-E1 cells and the role of p38MAPK, ERK1/2, NF-κB and SIRT1 in the process. METHODS: MC3T3-E1 cells were treated with different concentrations of P.e-LPS(0-50 mg/L) and 20 mg/L P.e-LPS for different time (0-24 h). The expression of IL-34 mRNA was detected by real-time reverse transcription-polymerase chain reaction (real time RT-PCR). MC3T3-E1 cells were pretreated with inhibitor of NF-κB(BAY 11-7082),inhibitor of p38MAPK (SB203580), inhibitor of ERK1/2 (PD98059), agonist of sirtuin1 (SIRT1) [resveratrol (RES)] and inhibitor of SIRT1 (EX-527) for 1 h, and then were treated with 20 mg/L P.e-LPS. The expression of IL-34 mRNA was detected by real time RT-PCR. Statistical analysis was performed using one-way ANOVA and Dunnett t test with SPSS 13.0 software package. RESULTS: The level of IL-34 mRNA increased significantly after treatment with different concentrations of P.e-LPS(0-50 mg/L),which indicated that P.e-LPS induced osteoblasts to express IL-34 mRNA in a dose-dependent manner. Maximal induction of IL-34 mRNA expression was observed in MC3T3-E1 cells treated with 20 mg/L P.e-LPS for 24 h.At 48 h, the expression of IL-34 mRNA decreased gradually. The mRNA of IL-34 decreased significantly after pretreatment with 10 μmol/L BAY-117082, SB203580 and PD98059 for 1 h. P.e-LPS-induced IL-34 upregulation was attenuated by pretreatment with RES, but increased by EX-527. CONCLUSIONS: These results suggest that P.e-LPS may mediate IL-34 mRNA expression in MC3T3-E1 cells. This process is dependent, at least in part, on p38MAPK, ERK1/2, NF-κB and SIRT1 signaling pathways.

Key words: Porphyromonas endodontalis, Lipopolysaeeharides, Osteoblast, Interleukin-34, Signaling pathways

CLC Number:

R780.2

YU Ya-qiong, GUO Jia-jie, QIU Li-hong, LI Xiao-lin, YANG Di, GUO Yan. Effect of lipopolysaccharides from Porphyromonas endodontalis on the expression of interleukin-34 in mouse osteoblasts[J]. Shanghai Journal of Stomatology, 2017, 26(1): 37-41.

References

[1] Lin H, Lee E, Hestir K, et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome [J]. Science, 2008, 320(5877): 807-811.
[2] Foucher ED, Blanchard S, Preisser L, et al. IL-34 induces the differentiation of human monocytes into immunosuppressive macrophages. antagonistic effects of GM-CSF and IFNγ [J]. PLoS One, 2013, 8(2): e56045.
[3] Chen Z, Buki K, Vääräniemi J, et al. The critical role of IL-34 in osteoclastogenesis [J]. PLoS One, 2011, 6(4): e18689.
[4] 于雅琼, 仇丽鸿, 郭佳杰, 等. 牙髓卟啉单胞菌脂多糖对小鼠成骨细胞巨噬细胞集落刺激因子表达的影响[J]. 中华口腔医学杂志, 2014, 49(9): 535- 539.
[5] Yu Y, Qiu L, Guo J, et al. TRIB3 mediates the expression of Wnt5a and activation of nuclear factor-κB in Porphyromonas endodontalis lipopolysaccharide-treated osteoblasts [J]. Mol Oral Microbiol, 2015, 30(4): 295-306.
[6] Hwang SJ, Choi B, Kang SS, et al. Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis[J]. Arthritis Res Ther, 2012, 14(1): R14.
[7] Tian Y, Shen H, Xia L, et al. Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production [J]. J Interferon Cytokine Res, 2013, 33(7): 398-401.
[8] Ciccia F, Alessandro R, Rodolico V, et al. IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14brightCD16 + monocytes [J]. Rheumatology (Oxford), 2013, 52(6): 1009-1017.
[9] Zwicker S, Martinez GL, Bosma M, et al. Interleukin 34: a new modulator of human and experimental inflammatory bowel disease [J]. Clin Sci (Lond), 2015, 129(3): 281-290.
[10] 马楠, 曲柳, 徐莉雅, 等. IL-34在慢性根尖周病损组织中的表达及临床意义 [J].上海口腔医学, 2016, 25(1): 53-57.
[11] Yu Y, Yang D, Qiu L, et al. Tumor necrosis factor-α induces interleukin-34 expression through nuclear factor-κB activation in MC3T3-E1 osteoblastic cells[J]. Mol Med Rep, 2014, 10(3): 1371-1376.
[12] Eda H, Shimada H, Beidler DR, et al. Proinflammatory cytokines, IL-1β and TNF-α, induce expression of interleukin-34 mRNA via JNK- and p44/42 MAPK-NF-κB pathway but not p38 pathway in osteoblasts[J]. Rheumatol Int, 2011, 31(11): 1525-1530.
[13] Chemel M, Le Goff B, Brion R, et al. Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients [J]. Ann Rheum Dis, 2012, 71(1): 150-154.
[14] Boström EA, Lundberg P. The newly discovered cytokine IL-34 is expressed in gingival fibroblasts, shows enhanced expression by pro-inflammatory cytokines, and stimulates osteoclast differentiation [J]. PLoS One, 2013, 8(12): e81665.
[15] Kamigaki M, Hide I, Yanase Y, et al. The Toll-like receptor 4-activated neuroprotective microglia subpopulation survives via granulocyte macrophage colony-stimulating factor and JAK2/STAT5 signaling [J]. Neurochem Int, 2016, 93（1）: 82-94.
[16] 贾舸, 仇丽鸿, 李任, 等. CD-14和Tool样受体在牙髓卟啉单胞菌脂多糖诱导成骨细胞白细胞介素6表达中的作用[J]. 中华口腔医学杂志, 2011, 46(9): 531-536.
[17] 吕游, 贾舸, 仇丽鸿, 等. 牙髓卟啉单胞菌脂多糖对成骨细胞p38丝裂原活化蛋白激酶和细胞外信号调节激酶1、2表达的影响 [J]. 上海口腔医学, 2012, 21(4): 389-392.
[18] 杨谛, 仇丽鸿, 李任, 等. 牙髓卟啉单胞菌内毒素诱导成骨细胞表达炎症因子的信号通路研究 [J]. 华西口腔医学杂志, 2010, 28(2): 135-138.
[19] 于雅琼, 郭佳杰, 仇丽鸿, 等. NF-κB在牙髓卟啉单胞菌脂多糖诱导小鼠成骨细胞白介素6表达中的作用[J]. 上海口腔医学, 2013, 22(4): 378-383.
[20] 曲柳, 仇丽鸿. SIRT1抑制炎症反应的研究进展 [J]. 中国实用口腔科杂志, 2013, 6(9): 564-568.
[21] Shen Z, Ajmo JM, Rogers CQ, et al. Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines[J]. Am J Physiol Gastrointest Liver Physiol, 2009, 296(5): G1047-1053.
[22] Lee SI, Min KS, Bae WJ, et al. Role of SIRT1 in heat stress- and lipopolysaccharide-induced immune and defense gene expression in human dental pulp cell[J]. J Endod, 2011, 37(11): 1525-1230.
[23] Li T, Zhang J, Feng J, et al. Resveratrol reduces acute lung injury in a LPS induced sepsis mouse model via activation of Sirt1[J]. Mol Med Rep, 2013, 7(6): 1889-1895.
[24] Tamaki N, Cristina Orihuela-Campos R, Inagaki Y, et al. Resveratrol improves oxidative stress and prevents the progression of periodontitis via the activation of the Sirt1/AMPK and the Nrf2/antioxidant defense pathways in a rat periodontitis model [J]. Free Radic Biol Med, 2014, 75: 222-229.
[25] Bhattarai G, Poudel SB, Kook SH, et al. Resveratrol prevents alveolar bone loss in an experimental rat model of periodontitis [J]. Acta Biomater, 2016, 29: 398-408.